Table 5. Pathways enriched in high-risk group by using gene set enrichment analysis (GSEA).

NAME	SIZE	ES	NES	NOM	FDR	FWER	RANK AT MAX	LEADING EDGE
				p		p
KEGG_VASCULAR_SMOOTH_MUSCLE_CONTRACTION	115	0.62	1.964702	0.002008	0.065481	0.026	11121	tags = 55%, list = 20%, signal = 68%
KEGG_HYPERTROPHIC_CARDIOMYOPATHY_HCM	83	0.59	1.955429	0	0.03834	0.031	9975	tags = 54%, list = 18%, signal = 66%
KEGG_ECM_RECEPTOR_INTERACTION	84	0.67	1.949449	0.002008	0.028178	0.034	9125	tags = 60%, list = 16%, signal = 71%
KEGG_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY_ARVC	74	0.6	1.912274	0.003876	0.034986	0.051	8727	tags = 53%, list = 16%, signal = 62%
KEGG_DILATED_CARDIOMYOPATHY	90	0.58	1.898705	0.001938	0.032262	0.058	8727	tags = 49%, list = 16%, signal = 58%
KEGG_TGF_BETA_SIGNALING_PATHWAY	85	0.62	1.866714	0.001992	0.045007	0.09	11089	tags = 59%, list = 20%, signal = 73%
KEGG_FOCAL_ADHESION	197	0.61	1.855329	0	0.04626	0.098	12655	tags = 60%, list = 23%, signal = 78%
KEGG_OOCYTE_MEIOSIS	110	0.62	1.850145	0.004107	0.044282	0.109	10925	tags = 56%, list = 20%, signal = 70%
KEGG_MAPK_SIGNALING_PATHWAY	265	0.54	1.843136	0.003937	0.044181	0.116	13695	tags = 52%, list = 25%, signal = 69%
KEGG_GAP_JUNCTION	90	0.57	1.835098	0.003861	0.043918	0.121	14440	tags = 58%, list = 26%, signal = 78%